Ligase Targeting Drug Development Summit
Evvnt Promotion / evvnt
07.05.2024 - 09.05.2024 The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
Kongressthemen
The development of mono- and bivalent degraders continues to gain traction, but biopharma faces challenges in rapidly discovering, validating, and utilizing novel E3 ligases. This leaves therapeutic opportunities untapped due to obstacles in ligase screening, structural characterization, and assaying therapeutic efficacy.
The development of mono- and bivalent degraders continues to gain traction, but biopharma faces challenges in rapidly discovering, validating, and utilizing novel E3 ligases. This leaves therapeutic opportunities untapped due to obstacles in ligase screening, structural characterization, and assaying therapeutic efficacy.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2174653-3?pid=4832
Speakers: Andreas Kraemer Principal Investigator Goethe University Frankfurt am Main and Structural Genomics Consortium, and more
URL:
Brochure: https://go.evvnt.com/2174653-3?pid=4832
Speakers: Andreas Kraemer Principal Investigator Goethe University Frankfurt am Main and Structural Genomics Consortium, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2174653-2?pid=4832
Frau Isabella Hunter
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
